Invention Grant
- Patent Title: Pazopanib formulation
-
Application No.: US16109143Application Date: 2018-08-22
-
Publication No.: US10596263B2Publication Date: 2020-03-24
- Inventor: Gossett Augustus Campbell , Helen Richardson , Peter A. Williams
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: A61K47/36
- IPC: A61K47/36 ; A61K47/32 ; A61K47/38 ; A61K47/46 ; A61K31/506 ; A61K9/00 ; A61K9/14 ; A61K9/16
Abstract:
A granulation formulation of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide or pharmaceutically acceptable salt thereof, which is adapted for reconstitution with an aqueous vehicle, and associated oral suspension.
Public/Granted literature
- US20180360971A1 PAZOPANIB FORMULATION Public/Granted day:2018-12-20
Information query
